BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Clinical Outcome
16 results:

  • 1. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors.
    Cristiani CM; Capone M; Garofalo C; Madonna G; Mallardo D; Tuffanelli M; Vanella V; Greco M; Foti DP; Viglietto G; Ascierto PA; Spits H; Carbone E
    Front Immunol; 2022; 13():811131. PubMed ID: 35173725
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.
    Niu Z; Li Y; Xu Y; Jiang W; Tao R; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(2):12193-12205. PubMed ID: 34783295
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
    Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gynecologic melanomas: A clinicopathologic and molecular analysis.
    Udager AM; Frisch NK; Hong LJ; Stasenko M; Johnston CM; Liu JR; Chan MP; Harms PW; Fullen DR; Orsini A; Thomas DG; Lowe L; Patel RM
    Gynecol Oncol; 2017 Nov; 147(2):351-357. PubMed ID: 28844540
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
    Jangard M; Zebary A; Ragnarsson-Olding B; Hansson J
    Melanoma Res; 2015 Jun; 25(3):185-8. PubMed ID: 25746036
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.
    Yuan J; Zhou J; Dong Z; Tandon S; Kuk D; Panageas KS; Wong P; Wu X; Naidoo J; Page DB; Wolchok JD; Hodi FS
    Cancer Immunol Res; 2014 Feb; 2(2):127-32. PubMed ID: 24778276
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
    Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
    J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment and characterization of a novel xenograft model of human gastrointestinal stromal tumor in mice.
    Moriyama M; Shimada Y; Nagata T; Omura T; Sekine S; Matsui K; Yoshioka I; Okumura T; Sawada S; Yoshida T; Tsukada K
    Anticancer Res; 2013 Jan; 33(1):175-81. PubMed ID: 23267143
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Intratumoral mast cell number is negatively correlated with tumor size and mitosis in dermatofibrosarcoma protuberans.
    Kim M; Cho KH; Lee JH; Chang MS; Cho S
    Exp Dermatol; 2012 Jul; 21(7):559-61. PubMed ID: 22716258
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
    Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F
    Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The biology and management of uveal melanoma.
    Sato T; Han F; Yamamoto A
    Curr Oncol Rep; 2008 Sep; 10(5):431-8. PubMed ID: 18706273
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Imatinib mesylate causes hypopigmentation in the skin.
    Tsao AS; Kantarjian H; Cortes J; O'Brien S; Talpaz M
    Cancer; 2003 Dec; 98(11):2483-7. PubMed ID: 14635084
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role and regulation of the thrombin receptor (PAR-1) in human melanoma.
    Tellez C; Bar-Eli M
    Oncogene; 2003 May; 22(20):3130-7. PubMed ID: 12789289
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.
    Sotlar K; Escribano L; Landt O; Möhrle S; Herrero S; Torrelo A; Lass U; Horny HP; Bültmann B
    Am J Pathol; 2003 Mar; 162(3):737-46. PubMed ID: 12598308
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.